BOOST Pharma Adds Sound Bioventures to Investor Syndicate with SEK 34 Million Investment to Advance Stem Cell Therapy for Osteogenesis Imperfecta

BOOST Pharma ApS announced that Sound Bioventures has joined its investor syndicate with a SEK 34 million investment. The financing will support continued clinical development of BT-101, a stem cell-based therapy for osteogenesis imperfecta.